Quick Answer
ONCOLYTICS BIOTECH INC reported Research And Development Expense of $13.31 million for the year ending 2025.
- ONCOLYTICS BIOTECH INC showed a decrease of -13.8% in Research And Development Expense from 2024 to 2025.
- This data is from ONCOLYTICS BIOTECH INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), ONCOLYTICS BIOTECH INC's Research And Development Expense has grown by 54.8%.
- Historical annual values: Fiscal year 2025: $13.31 million | Fiscal year 2024: $15.44 million | Fiscal year 2023: $17.71 million | Fiscal year 2022: $15.43 million | Fiscal year 2021: $12.92 million | Fiscal year 2020: $12.95 million | Fiscal year 2019: $10.82 million | Fiscal year 2018: $10.03 million | Fiscal year 2017: $9.39 million | Fiscal year 2016: $9.77 million | Fiscal year 2015: $8.60 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: